GILEAD SCIENCES INC 4
4 · GILEAD SCIENCES INC · Filed Aug 3, 2016
Insider Transaction Report
Form 4
Carter Paul Rutherford
EVP Commercial Ops
Transactions
- Exercise/Conversion
Common Stock
2016-08-01$40.56/sh+1,817$73,698→ 64,122 total - Exercise/Conversion
Common Stock
2016-08-01$24.91/sh+183$4,558→ 64,305 total - Sale
Common Stock
2016-08-01$79.81/sh−2,000$159,620→ 62,305 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2016-08-01−1,817→ 4,803 totalExercise: $40.56Exp: 2023-02-01→ Common Stock (1,817 underlying) - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2016-08-01−183→ 26,043 totalExercise: $24.91Exp: 2019-07-29→ Common Stock (183 underlying)
Footnotes (3)
- [F1]The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- [F2]The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- [F3]The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.